Skip to main content

Lamisil Once Side Effects

Generic name: terbinafine topical

Medically reviewed by Drugs.com. Last updated on Dec 20, 2023.

Note: This document provides detailed information about Lamisil Once Side Effects associated with terbinafine topical. Some dosage forms listed on this page may not apply specifically to the brand name Lamisil Once.

Applies to terbinafine topical: topical cream, topical gel/jelly, topical spray.

Serious side effects of Lamisil Once

Along with its needed effects, terbinafine topical (the active ingredient contained in Lamisil Once) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor as soon as possible if any of the following side effects occur while taking terbinafine topical:

Rare side effects

  • dryness
  • redness
  • itching
  • burning
  • peeling
  • rash
  • stinging
  • tingling
  • or other signs of skin irritation not present before use of this medicine

For healthcare professionals

Applies to terbinafine topical: topical cream, topical gel, topical solution, topical spray.

General adverse events

Therapy was discontinued in clinical trials by 0.2% of patients treated with terbinafine solution and 0.6% of patients treated with placebo.[Ref]

Dermatologic

Dermatologic side effects have included burning or irritation (1.3%), itching (1.1%), skin exfoliation (1%), and erythematous rash (0.9%).[Ref]

References

1. (2001) "Product Information. Lamisil (terbinafine)." Sandoz Pharmaceuticals Corporation

More about Lamisil Once (terbinafine topical)

Professional resources

Other formulations

Related treatment guides

Further information

Lamisil Once side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.